Engracio P. Cortes
- Oncology top 10%
- Cancer Treatment and Pharmacology 4
- Peptidase Inhibition and Analysis 3
- Dermatology top 5%
-
- Chemotherapy-induced cardiotoxicity and mitigation 6
-
- Sarcoma Diagnosis and Treatment 4
- Pathology and Forensic Medicine top 10%
-
- Radiopharmaceutical Chemistry and Applications 4
-
- Colorectal and Anal Carcinomas 3
-
- Cervical Cancer and HPV Research 2
-
- Neuroblastoma Research and Treatments 2
- Co-authors
- James F. HollandJaw J. WangLucius F. SinksOliver GlidewellH. J. SennJohannes BlomArthur BankT Ohnuma
- Journals
- Cancer (5 papers)Journal of Surgical Oncology (3 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesItalyIreland
In The Last Decade
Engracio P. Cortes
21 papers receiving 799 citations
Peers
Comparison fields: 5 of 85
- Oncology 439
- Dermatology 126
- Cardiology and Cardiovascular Medicine 275
- Pulmonary and Respiratory Medicine 372
- Pathology and Forensic Medicine 116
Countries citing papers authored by Engracio P. Cortes
This map shows the geographic impact of Engracio P. Cortes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Engracio P. Cortes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Engracio P. Cortes more than expected).
Fields of papers citing papers by Engracio P. Cortes
This network shows the impact of papers produced by Engracio P. Cortes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Engracio P. Cortes. The network helps show where Engracio P. Cortes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Engracio P. Cortes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 0 | |
| 2 | 2005 | 6 | |
| 3 | 1996 | 17 | |
| 4 | 1996 | 10 | |
| 5 | 1995 | 18 | |
| 6 | 1985 | 5 | |
| 7 | Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study. | 1982 | 4 |
| 8 | 1982 | 7 | |
| 9 | 1981 | 19 | |
| 10 | 1981 | 15 | |
| 11 | 1981 | 3 | |
| 12 | 1979 | 15 | |
| 13 | Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10. | 1978 | 56 |
| 14 | 1977 | 6 | |
| 15 | 1974 | 238 | |
| 16 | 1973 | 80 | |
| 17 | 1972 | 114 | |
| 18 | Effects of mithramycin on bone resorption in vitro. | 1972 | 13 |
| 19 | 1971 | 174 | |
| 20 | 1971 | 6 |
About Engracio P. Cortes
Engracio P. Cortes is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Otorhinolaryngology, having authored 22 papers that have together received 901 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Cancer Treatment and Pharmacology (4 papers), Sarcoma Diagnosis and Treatment (4 papers), Peptidase Inhibition and Analysis (3 papers), Colorectal and Anal Carcinomas (3 papers), Cervical Cancer and HPV Research (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Oncology (439 citations), Dermatology (126 citations) and Cardiology and Cardiovascular Medicine (275 citations). Engracio P. Cortes has collaborated with scholars based in United States, Italy and Ireland. Frequent co-authors include James F. Holland, Jaw J. Wang, Lucius F. Sinks, Oliver Glidewell, H. J. Senn, Johannes Blom, Arthur Bank, T Ohnuma, Joseph J. Barlow and M. Steven Piver. Their work appears in journals such as Cancer, Journal of Surgical Oncology, Journal of Clinical Oncology, Annals of Internal Medicine and Clinical Orthopaedics and Related Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.